Incidence and disease burden of bronchiectasis in systemic lupus erythematosus: a nationwide population-based study in Korea

초록

Objectives: Pulmonary abnormalities, such as interstitial lung disease, have been relatively well studied in patients with systemic lupus erythematosus (SLE). However, it remains unclear whether the risk of bronchiectasis and its associated disease burden are increased in SLE. Methods: Using the Korean National Health Insurance Service dataset, we conducted a population-based matched cohort study involving adults aged ≥20 years diagnosed with SLE (SLE cohort) between 2002 and 2012 and a 1:4 age, sex and health insurance service-matched cohort (matched controls). Beginning 1 year after enrolment, participants were followed until the date of a bronchiectasis diagnosis, death or 31 December 2019, whichever came first. Results: During a median follow-up of 12.8 years (IQR 10.0–16.0 years), the incidence rate of bronchiectasis was higher in the SLE cohort than in the matched controls (374.8 vs 236.2/100 000 person-years, p<0.001). The SLE cohort showed a 1.46-fold (95% CI 1.22 to 1.76) increased risk of developing bronchiectasis compared with the matched cohort. Within the SLE cohort, age older than 40 years (highest adjusted HR (aHR) in those ≥70 years 25.08, 95% CI 7.62 to 82.53) and asthma (aHR 1.73, 95% CI 1.11 to 2.70) were associated with an increased risk of bronchiectasis. In contrast, obesity was inversely associated with the risk of bronchiectasis (aHR 0.56, 95% CI 0.38 to 0.82). Individuals with SLE who developed bronchiectasis had significantly higher rates of mortality, emergency department visits and hospitalisations than those who did not develop bronchiectasis. Conclusions: The risk of bronchiectasis was higher in individuals with SLE than in controls, and its development was associated with a worse disease course, higher mortality during follow-up and increased healthcare utilisation.

키워드